An infographic summarising C-peptide, a key biomarker of beta-cell function
Learning Objectives
Understand that C-peptide is a by-product of insulin synthesis
Recognize C-peptide's role in understanding disease status in T1D
Appreciate C-peptide's potential as a diagnostic and prognostic tool
C-peptide is a key tool in autoimmune type 1 diabetes (T1D) management. It aids diagnosis, disease monitoring, and is a key biomarker for beta-cell function and endogenous insulin secretion. C-peptide measurement during a mixed-meal tolerance test is the gold standard for assessing beta-cell function. Residual C-peptide predicts positive outcomes, fewer diabetes-related complications, and improved glycemic control, meaning C-peptide can potentially guide early interventions to delay or prevent the clinical onset of T1D.
Prof. Haller explains that educating caregivers of children with T1D is important so they understand progression risk and the benefits of lifestyle changes.
BR1DGE is a non-promotional global medical education program designed to advance understanding around presymptomatic type 1 diabetes and is provided by Sanofi.
This website is intended only for use by healthcare professionals in Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Denmark, Finland, France, Germany, India, Ireland, Israel, Italy, Japan, Kingdom of Saudi Arabia, Kuwait, Luxembourg, Mexico, Norway, Portugal, Qatar, Russian Federation, Spain, Sweden, The Netherlands, The United Arab Emirates, and The United Kingdom (UK).
Note: Healthcare professionals from Ireland or The UK must click the second link below to be redirected to the local website.
Are you a healthcare professional from one of the countries listed above?
You are now being redirected to a third-party website.
You are now being redirected to a third-party website.
You are about to leave the Sanofi-sponsored BR1DGE website and enter a third-party website. This link is provided as a service and does not imply endorsement by Sanofi of the information contained on the third-party website. Sanofi is not responsible for the content, views, or privacy policies of this third-party site.